EnBio Holdings, Inc. (JP:6092)
:6092
6092 Stock Chart & Stats
¥598.00
-¥2.00(-0.33%)
At close: 4:00 PM EST
¥598.00
-¥2.00(-0.33%)
Day’s Range― - ―
52-Week Range¥500.00 - ¥855.00
Previous CloseN/A
Volume5.80K
Average Volume (3M)25.91K
Market Cap
¥6.66B
Enterprise Value¥13.20B
Total Cash (Recent Filing)¥3.19B
Total Debt (Recent Filing)¥10.28B
Price to Earnings (P/E)―
Beta0.58
Next Earnings
May 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.54%
Share Statistics
EPS (TTM)-75.25
Shares Outstanding8,175,200
10 Day Avg. Volume21,320
30 Day Avg. Volume25,910
Financial Highlights & Ratios
PEG Ratio-0.29
Price to Book (P/B)0.53
Price to Sales (P/S)0.45
P/FCF Ratio-3.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Specialized Remediation And Land Redevelopment ModelEnBio's focus on soil/groundwater remediation plus converting cleaned sites into redevelopment opportunities creates durable, project-driven revenue streams. Technical expertise and long project cycles foster sticky client relationships with industrial and government customers and create entry barriers.
Historically Healthy Margins And ProfitabilityPrior multi-year margin strength demonstrates operational capability to price and execute remediation projects profitably. That track record indicates underlying unit economics that can support recovery in earnings if volumes stabilize and project mix normalizes, underpinning longer-term cash generation potential.
Improving Leverage Trend And Equity GrowthAn improving leverage trend and rising equity provide greater financial flexibility and a larger buffer against shocks. While debt remains material, the direction of improvement signals management has been strengthening the capital base, reducing medium-term refinancing and solvency risks.
Bears Say
Collapse In Operating And Free Cash FlowA sharp drop to near-zero operating cash flow and a large negative free cash flow in 2025 materially erode financial flexibility. Persistent FCF holes force external financing, constrain capex and working-capital management, and increase risk that profitable accounting earnings do not translate to available cash.
Elevated Leverage With Falling Returns On EquityHigh debt relative to equity combined with declining ROE amplifies downside risk: interest and principal obligations magnify earnings volatility, reduce borrowing headroom, and mean lower returns for shareholders. This limits ability to fund growth or absorb further margin or revenue shocks.
Sharp Revenue Contraction And Weaker Margins In 2025A pronounced revenue decline and margin compression suggest demand or project pipeline deterioration. If structural rather than temporary, this undermines operating leverage, pricing power and the company's ability to cover fixed costs, putting sustained pressure on cash flow and competitive positioning.
EnBio Holdings, Inc. News
6092 FAQ
What was EnBio Holdings, Inc.’s price range in the past 12 months?
EnBio Holdings, Inc. lowest stock price was ¥500.00 and its highest was ¥855.00 in the past 12 months.
What is EnBio Holdings, Inc.’s market cap?
EnBio Holdings, Inc.’s market cap is ¥6.66B.
When is EnBio Holdings, Inc.’s upcoming earnings report date?
EnBio Holdings, Inc.’s upcoming earnings report date is May 20, 2026 which is in 44 days.
How were EnBio Holdings, Inc.’s earnings last quarter?
EnBio Holdings, Inc. released its earnings results on Feb 13, 2026. The company reported -¥75.25 earnings per share for the quarter, missing the consensus estimate of N/A by -¥75.25.
Is EnBio Holdings, Inc. overvalued?
According to Wall Street analysts EnBio Holdings, Inc.’s price is currently Overvalued.
Does EnBio Holdings, Inc. pay dividends?
EnBio Holdings, Inc. pays a Annually dividend of ¥9 which represents an annual dividend yield of 1.54%. See more information on EnBio Holdings, Inc. dividends here
What is EnBio Holdings, Inc.’s EPS estimate?
EnBio Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EnBio Holdings, Inc. have?
EnBio Holdings, Inc. has 8,175,200 shares outstanding.
What happened to EnBio Holdings, Inc.’s price movement after its last earnings report?
EnBio Holdings, Inc. reported an EPS of -¥75.25 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.165%.
Which hedge fund is a major shareholder of EnBio Holdings, Inc.?
Currently, no hedge funds are holding shares in JP:6092
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
EnBio Holdings, Inc.
EnBio Holdings Co., Ltd. engages in soil and groundwater contamination, and renewable energy businesses in Japan. It imports and sells equipment, materials, and cleaning agents; and purchases, sells, and leases contaminated land. The company is also involved in solar power; biomass power generation; renewable energy power generation; water resource development; and ethical consumption promotion businesses. EnBio Holdings Co., Ltd. was incorporated in 1999 and is headquartered in Tokyo, Japan.
Technical Analysis
Paraca Inc.
―
SHIKIGAKU Co., Ltd.
―
Nakabayashi Co., Ltd.
―
PHYZ Holdings, Inc.
―
Biken Techno Corporation
―